
NVP-MELK8a hydrochloride
CAS No. 2096992-20-8
NVP-MELK8a hydrochloride( MELK8a hydrochloride )
Catalog No. M13303 CAS No. 2096992-20-8
NVP-MELK8a hydrochloride (MELK8a hydrochloride)?is a novel potent, and selective MELK inhibitor with IC50 of 2 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 312 | Get Quote |
![]() ![]() |
10MG | 447 | Get Quote |
![]() ![]() |
25MG | 714 | Get Quote |
![]() ![]() |
50MG | 1017 | Get Quote |
![]() ![]() |
100MG | 1368 | Get Quote |
![]() ![]() |
500MG | 2673 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameNVP-MELK8a hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionNVP-MELK8a hydrochloride (MELK8a hydrochloride)?is a novel potent, and selective MELK inhibitor with IC50 of 2 nM.
-
DescriptionNVP-MELK8a hydrochloride (MELK8a hydrochloride)?is a novel potent, and selective MELK inhibitor with IC50 of 2 nM; exhibits high selectivity with only 7 off-target kinases inhibited >85% against 456 kinases at 1 uM, Flt3 (IC50=0.18 uM), Haspin (IC50=0.19 uM), PDGFRα (IC50=0.42 uM); exhibits growth inhibition of MDA-MD-468 cells with IC50 of 0.11 uM, and increases cells harboring 4N DNA content.
-
In VitroMELK-8a remains very potent (IC50=140 nM) when the ATP concentration in the biochemical assay is shifted from 20 μM to 2 mM. Its potency is well tracked between full-length MELK versus catalytic domain construct (5 nM versus 2 nM). It only inhibits seven off-target kinases in addition to MELK with >85% inhibition of binding at 1 μM demonstrating great selectivity. The compound is at least 90-fold more selective in targeting MELK in all cases. MELK-8a is fairly soluble (0.22 g/L at pH 6.8) and shows a good permeability in the Caco-2 assay. MELK-8a inhibits the growth of MDA-MB-468 cells and MCF-7 cells with an IC50 of approximately 0.06 and 1.2 μM, respectively.
-
In VivoSubcutaneous administration of MELK-8a at 30 mg/kg in C57BL/6 mice results in good plasma exposure. The compound adsorption into the systemic circulation is rapid (Tmax=0.4 h) and peak plasma concentration reaches 6.6 μM. An ascending dose PK study in female athymic nude mice shows that the rate of compound release is maximal at 120 mg/kg and all clearance mechanisms can be saturated at 240 mg/kg. However, when administered orally at 10 mg/kg in C57BL/6 male mice, it shows very poor PK (3.6% oral bioavailability) consistent with very high in vivo clearance.
-
SynonymsMELK8a hydrochloride
-
PathwayPI3K/Akt/mTOR signaling
-
TargetMELK
-
RecptorMELK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2096992-20-8
-
Formula Weight469.02212
-
Molecular FormulaC25H33ClN6O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 8.6 mg/mL (Need ultrasonic and warming)
-
SMILESCN1CCN(CC1)C2=CC=C(C=C2)N3C=C(C=N3)C4=C(C=NC=C4)OCC5CCNCC5.Cl
-
Chemical NamePiperazine, 1-methyl-4-[4-[4-[3-(4-piperidinylmethoxy)-4-pyridinyl]-1H-pyrazol-1-yl]phenyl]-,hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Touré BB, et al. J Med Chem. 2016 May 26;59(10):4711-23.
2. Huang HT, et al. Elife. 2017 Sep 19;6. pii: e26693.
molnova catalog



related products